<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00736723</url>
  </required_header>
  <id_info>
    <org_study_id>Anae_ICU_Ulm_NT-proBNP</org_study_id>
    <nct_id>NCT00736723</nct_id>
  </id_info>
  <brief_title>NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock</brief_title>
  <acronym>NICUPS</acronym>
  <official_title>NT-proBNP in Postoperative/Posttraumatic Critically Ill Patients With Severe SIRS/Sepsis and Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the course of NT-proBNP plasma concentrations in
      the context of confounding parameters in postoperative/posttraumatic critically ill patients
      with severe SIRS/sepsis and shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the recent sepsis-definitions, myocardial depression is included in the definition of
      severe sepsis, indicated as lowered cardiac index or echocardiographically documented cardiac
      dysfunction. Myocardial dysfunction occurs in greater than 50% of patients with severe sepsis
      and septic shock. In this context, B-type natriuretic peptid (BNP) from ventricular myocytes
      may serve as a surrogate biomarker for the evaluation and quantification of myocardial
      dysfunction. Biologically active BNP is cleaved into inactive NT-proBNP, which is supposed to
      be a better marker of myocardial dysfunction and prognosis in patients with severe sepsis and
      septic shock. However, severity of illness dependent association of myocardial dysfunction,
      especially left ventricular diastolic function, dosage of norepinephrine, NT-proBNP and
      biomarker plasma concentrations has not been systematically investigated in
      postoperative/posttraumatic patients in septic shock or volume-deficiency/hemorrhagic shock.
      Moreover, data regarding NT-proBNP plasma concentrations and renal function in
      postoperative/posttraumatic patients are sparse. Therefore, this prospective observational
      study will enroll n= 200 postoperative/posttraumatic patients to monitor longitudinally
      NT-proBNP, biomarkers, and cell surface markers on leukocytes to find out whether there is a
      discriminating pattern of myocardial dysfunction, NT-proBNP and biomarkers in patients with
      non-septic or septic shock, respectively, and with beneficial or harmful outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pattern of NT-proBNP, Biomarkers and Surface Markers on Leukocytes</measure>
    <time_frame>01 July 2008 to 31 Dec 2008</time_frame>
    <description>maximal NT-proBNP concentrations in critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealingnonseptic and septic shock</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>SIRS</condition>
  <condition>Sepsis</condition>
  <condition>Shock</condition>
  <condition>Critically Ill</condition>
  <condition>Multiple Organ Dysfunction Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients non-septic shock</arm_group_label>
    <description>Postoperative/posttraumatic critically ill patients with non-septic shock</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients septic shock</arm_group_label>
    <description>Postoperative/posttraumatic critically ill patients with septic shock</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, white blood cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Postoperative/posttraumatic critically ill patients admitted to the intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Critically ill, postoperative/posttraumatic patients with severe systemic inflammatory
             response syndrome (SIRS) or severe sepsis

        Exclusion Criteria:

          -  Life expectancy &lt; 24 hours

          -  Participation in other trials

          -  Known or suspected pregnancy

          -  Contraindications for transesophageal echocardiography (TEE): severe disease of the
             esophagus (hernia, strictures, esophageal resection, severe bleeding disorders)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Weiss, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinic of Anesthesiology</name>
      <address>
        <city>Ulm</city>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Weiss M, Huber M, Nass M, Huber-Lang M, Koenig W, Schneider M. NT-proBNP and HMGB1 in surgical critically ill patients with hypovolemic or septic shock.Infection Suppl. II September 2011; 39: S116-117 5th International Congress of the German Sepsis Society, Weimar Sepsis Update Bridging The Gap, Weimar, 07. - 10.09.2011.</citation>
  </results_reference>
  <results_reference>
    <citation>Weiss M, Huber M, Nass M, Huber-Lang M, Koenig W, Schneider M. NT-proBNP serum concentrations in surgical critically ill patients with non-septic and septic shock. INNOVATIVE JOURNAL OF MEDICAL AND HEALTH SCIENCE 3 (4): 177-184, 2013.</citation>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2008</study_first_submitted>
  <study_first_submitted_qc>August 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2008</study_first_posted>
  <results_first_submitted>December 2, 2015</results_first_submitted>
  <results_first_submitted_qc>November 24, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 20, 2017</results_first_posted>
  <last_update_submitted>November 24, 2016</last_update_submitted>
  <last_update_submitted_qc>November 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Manfred Weiss</investigator_full_name>
    <investigator_title>Professor, MD, MBA</investigator_title>
  </responsible_party>
  <keyword>NT-proBNP</keyword>
  <keyword>myocardial dysfunction</keyword>
  <keyword>humans</keyword>
  <keyword>patients</keyword>
  <keyword>polytrauma</keyword>
  <keyword>complement</keyword>
  <keyword>inflammation</keyword>
  <keyword>inflammatory response</keyword>
  <keyword>biomarkers</keyword>
  <keyword>cytokines</keyword>
  <keyword>cell surface markers</keyword>
  <keyword>functional polymorphisms</keyword>
  <keyword>infections</keyword>
  <keyword>systemic inflammatory response syndrome</keyword>
  <keyword>SIRS</keyword>
  <keyword>sepsis</keyword>
  <keyword>severe sepsis</keyword>
  <keyword>shock</keyword>
  <keyword>organ dysfunctions</keyword>
  <keyword>SOFA</keyword>
  <keyword>severity of disease</keyword>
  <keyword>APACHEII</keyword>
  <keyword>SAPSII</keyword>
  <keyword>SPAPS3</keyword>
  <keyword>length of stay</keyword>
  <keyword>outcome</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Multiple Organ Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients With Non-septic Shock</title>
          <description>critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealing non-septic shock</description>
        </group>
        <group group_id="P2">
          <title>Patients With Septic Shock</title>
          <description>critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealing septic shock</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>surveyed daily for sepsis, organ dysfunctions and shock</population>
      <group_list>
        <group group_id="B1">
          <title>Postoperative/Posttraumatic Patients With Non-septic Shock</title>
          <description>Postoperative/posttraumatic critically ill patients with non-septic shock</description>
        </group>
        <group group_id="B2">
          <title>Postoperative/Posttraumatic Patients With Septic Shock</title>
          <description>Postoperative/posttraumatic critically ill patients with septic shock</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" lower_limit="20" upper_limit="80"/>
                    <measurement group_id="B2" value="60" lower_limit="37" upper_limit="88"/>
                    <measurement group_id="B3" value="57" lower_limit="20" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pattern of NT-proBNP, Biomarkers and Surface Markers on Leukocytes</title>
        <description>maximal NT-proBNP concentrations in critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealingnonseptic and septic shock</description>
        <time_frame>01 July 2008 to 31 Dec 2008</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients Non-septic Shock</title>
            <description>Postoperative/posttraumatic critically ill patients with non-septic shock</description>
          </group>
          <group group_id="O2">
            <title>Patients Septic Shock</title>
            <description>Postoperative/posttraumatic critically ill patients with septic shock</description>
          </group>
        </group_list>
        <measure>
          <title>Pattern of NT-proBNP, Biomarkers and Surface Markers on Leukocytes</title>
          <description>maximal NT-proBNP concentrations in critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealingnonseptic and septic shock</description>
          <units>pg/ml</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="902" lower_limit="39" upper_limit="31,937"/>
                    <measurement group_id="O2" value="4,429" lower_limit="193" upper_limit="35,000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Postoperative/Posttraumatic Patients With Non-septic Shock</title>
          <description>Postoperative/posttraumatic critically ill patients with non-septic shock</description>
        </group>
        <group group_id="E2">
          <title>Postoperative/Posttraumatic Patients With Septi</title>
          <description>Postoperative/posttraumatic critically ill patients with septic shock</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Myocardial depression has not been verified in our patients by a low cardiac index or by echocardiography</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Prof. Dr. Manfred Weiss</name_or_title>
      <organization>University</organization>
      <phone>#49 731 500 60226</phone>
      <email>manfred.weiss@uni-ulm.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

